Position in APGE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,591,067
New position
Shares Held
155,135
first reported quarter
Ownership
0.205%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#63
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 13%
Shared 87%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Sagefield Capital LP holds $35,402,626 across 4 Biotechnology names. APGE ranks #1 (58.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
155,135 | $20,591,067 | |
| 2 | TECH |
BIO-TECHNE Corp
|
209,647 | $14,811,559 | |
| 3 | 569,481 | $0 | |||
| 4 | 196,481 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,591,067 | 155,135 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||